Constipation May Not Link with Colorectal Cancer
Folks are considered constipated if they have three or fewer bowel movements a week. Doctors often refer these individuals to get a colonoscopy screening. But is that the right move?
Bone Loss Rx Didn't Lower Cancer Risk
It’s always exciting when researchers find a new benefit for an existing medication. One type of medicine that treats bone loss has been shown to have anti-cancer properties.
Sedation and Cancer Screening Complications
Maybe you've heard people say they don't want to have a colonoscopy because bad things can happen. True – bad things can happen, but complications are very unusual.
Too Many Seniors Getting Colonoscopies?
During Colorectal Cancer Awareness Month, we’ve been hearing about the vital importance of colorectal cancer screening. But some people may actually be getting screened too often.
Lowering Your Risk of Colorectal Cancer
March is Colorectal Cancer Awareness Month. Are you aware of the different types of screenings? And are you aware of which of these is the most effective?
Bowel Troubles? Time to Visit a Doctor
When it comes to colorectal cancer, the shortest possible time between the start of symptoms, diagnosis and treatment is best. Ignoring symptoms only delays necessary treatments.
The Obesity-Inactivity-Cancer Chain
The link between obesity and cancer is nothing new. Lack of regular exercise and cancer are also teammates. A new study has added some links to this chain of knowledge.
How To Triple Cancer Screening Participation
Doctors urge patients to start colorectal cancer screenings at age 50. But a large number of patients either ignore the recommendations or don’t get the screenings at all. Researchers have found a couple of ways to help folks get the test that could save their lives.
Predicting Chemotherapy Success
When chemotherapy is prescribed for colorectal cancer, doctors don’t always know if it will work for an individual treatment. A new tool might help predict success.
Multiple Sclerosis Rx Might Treat Cancer
The medication Gilenya ( fingolimod ) has been used to treat multiple sclerosis since 2008. Very preliminary studies suggest that it may have a future as an anti-cancer medication.